Ethyl 5-Methyl-1H-1,2,4-triazole-3-carboxylateis used as a reagent in the synthesis of low- molecular derivatives of 1,2,4-triazole. It is also used as a reagent in the preparation of heterocyclic modulators of HIF activity which is used in treatment of cancer and other hypoxia mediated diseases.
参考文献
Chudinov, M., et al.: Vestn. MITKHT, 6, 66 (2011); Jones, P., et al.: Preparation of heterocyclic modulators of HIF activity for the treatment of cancer and other hypoxia-mediated diseases, WO Patent 2014031936, Feb 27, 2014;
沪ICP备17019645号
400-821-0725
